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Xanthine-based photoaffinity probes allow
assessment of ligand engagement by TRPC5
channels†
Claudia C. Bauer,‡a Aisling Minard,‡ab Isabelle B. Pickles,‡ab Katie J. Simmons,a
Eulashini Chuntharpursat-Bon,a Matthew P. Burnham,c Nikil Kapur,d
David J. Beech,a Stephen P. Muench, ef Megan H. Wright, bf
Stuart L. Warrinerbf and Robin S. Bon *af
TRPC1/4/5 cation channels are emerging drug targets for the treatment of, amongst others, central
nervous system (CNS) disorders, kidney disease, and cardiovascular and metabolic disease. Various
small-molecule TRPC1/4/5 modulators have been reported, including highly potent xanthine derivatives
that distinguish between specific TRPC1/4/5 tetramers. However, tools to profile ligand engagement
by TRPC1/4/5 channels in live cells are lacking. Here, we report a set of potent xanthine-based
photoaffinity probes that functionally mimic the xanthines Pico145 and AM237. Using these probes, we
have developed a photoaffinity labelling protocol for TRPC5 channels, providing the first method for the
quantitative assessment of binding interactions of TRPC5 with small molecules in cells. This method
could be important for drug discovery efforts targeting the xanthine/lipid binding site of TRPC1/4/5
channels.
Introduction
Transient Receptor Potential Canonical (TRPC) proteins are
members of the TRP superfamily, which also includes TRPV, TRPA
and TRPM.1–8 Like other TRPs, TRPC proteins form tetrameric,
non-selective cation channels permeable by Na+ and Ca2+. Based
on sequence homology, the human TRPC proteins are divided into
two clusters: TRPC1/4/5 and TRPC3/6/7,9 while TRPC2 is encoded
by a pseudogene in human.10 TRPC4 and TRPC5 are the most
closely related TRPC proteins7 (70% sequence identity; BLAST
search8). TRPC1/4/5 proteins can assemble to form homo- or
heterotetrameric channels, each with their own biophysical
characteristics (e.g., voltage dependence, ion selectivity), cellular
function, and pharmacological profile.11 TRPC1 may not form
functional homomeric channels, but is an important contributor
to heteromeric channels, for example with TRPC4 and/or
TRPC5.1,6,9–13 However, there remains a lack of insight into
the exact compositions and stoichiometries of native TRPC1/4/5
channels, which may vary depending on, e.g., cell type, tissue and
cellular state. The implication of TRPC1/4/5 in a wide range of
physiological and pathological mechanisms has driven the search
for potent and selective channel modulators for studies in cells,
tissues and animal models.11,12 Because disruption of the Trpc4/5
genes13 and global expression of a dominant-negative mutant
TRPC514 do not cause catastrophic phenotypes in rodents,
TRPC1/4/5 inhibition may be particularly promising as a thera-
peutic strategy. Indeed, clinical trials with at least two TRPC1/4/5
inhibitors have been announced by Hydra Biosciences/Boehringer
Ingelheim (the TRPC4/5 channel inhibitor BI 135889 for
treatment of anxiety/CNS disorders) and Goldfinch Bio (the
TRPC5 channel inhibitor GFB-887 for genetically-driven kidney
disease). The structures of these clinical candidates have not
been disclosed to date.
Chemically-diverse small-molecule TRPC1/4/5 modulators
have been reported, but for most of these the modes-of-action
are poorly understood.2,11,12,15,16 Cellular targets may be
diverse, and even direct binders may have different TRPC1/4/5
binding sites. The most potent, selective and efficacious TRPC1/4/5
activator is the natural product ()-englerin A (EA).17–19
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Although EA has been used in animals,20 its toxicity19,21 and
instability in rodent plasma19 need to be carefully considered
in study design. The most promising and well-characterised
TRPC1/4/5 inhibitors are two closely-related xanthines, Pico145
1 (also called HC-608) and HC-070 2, which originally appeared
in a patent assigned to Hydra Biosciences (Fig. 1).22 Pico145 is
the most potent inhibitor of TRPC1/4/5 channels to date,23,24
with the highest potencies against heteromeric channels and
high selectivity against 8 related ion channels. Just et al.
reported the anxiolytic and antidepressant effects in mice of
HC-070.25 As part of this study, activities of HC-070 and Pico145
were confirmed against human, mouse and rat TRPC1/4/5
channels. In addition, both compounds were shown to be
4400-fold selective against 4100 ion channels, receptors,
enzymes, kinases and transporters (42000-fold for most) and
to be orally bioavailable. Therefore, Pico145 and HC-070 are
considered valuable chemical probes for functional studies of
TRPC1/4/5 channels in cells and animals.21,25–27 In addition, we
reported that AM237, a close analogue of Pico145 and HC-070,
is an activator of homomeric TRPC5:C5 channels, but an
inhibitor of TRPC4:C4, TRPC1:C5 and TRPC1:C4 channels.28
Pico145 is a competitive antagonist of both EA- and AM237-
mediated TRPC5:C5 activation.17,28 Pico145 also inhibits
TRPC1/4/5 channels activated by carbachol25 and sphingosine-1-
phosphate (S1P)23 (which act via G-protein signalling), and by
the direct agonist Gd3+, although low concentrations of Pico145
(10 pM) can also potentiate Gd3+-induced currents mediated by
TRPC4.23 These data suggest that xanthines such as Pico145
and AM237 occupy a well-defined, high-affinity binding site
essential to TRPC1/4/5 channel gating to stabilise open or closed
TRPC5 channel states, depending on subunit composition and
xanthine substituent pattern. We recently reported cryo-EM struc-
tures of human TRPC5:C5 in complex with Pico145, revealing that
Pico145 binds to a conserved lipid binding site of TRPC5, where
it displaces a bound phospholipid.29 A subsequent report of
a cryo-EM structure of TRPC5:C5 in complex with HC-07030
suggested that HC-070 binds to the same site as Pico145, with a
near-identical binding pose. These studies highlight targeting of
the conserved lipid binding site of TRPC1/4/5 channels as a
promising strategy for TRPC1/4/5 drug discovery.
An important step in drug discovery is the assessment
of cellular target engagement and occupancy by candidate
molecules.31–34 Photoaffinity labelling (PAL)35–37 can be used
to identify, characterise and validate interactions of small
molecules with membrane proteins and ion channels,38–42
which may readily lose their affinity for non-covalent ligands
under various experimental conditions. PAL results in the
formation of covalent bonds between a photoaffinity probe
and its cellular target(s). The initiation of labelling with a
specific wavelength of light enables spatio-temporal control
and allows straight-forward control experiments in the absence
of light.
The structure and pharmacological profile of a photoaffinity
probe must closely resemble those of its parent compound, and
the placement of the photoreactive group must favour inter-
molecular crosslinking over intramolecular rearrangement.40
Fig. 1 Structures of xanthine derivatives discussed in this work. (A) Structures of previously described xanthine-based TRPC1/4/5 modulators Pico145
(HC-608) 1, HC-070 2 and AM237 3. (B) Structures of new xanthine-based photoaffinity probes described in this work: Pico145-DA 4 (Pico145-diazirine),
Pico145-DAAlk 5 (Pico145-diazirine-alkyne), Pico145-DA2 6 (Pico145-diazirine-2) and Pico145-DAAlk2 7 (Pico145-diazirine-alkyne-2). Changes to the
Pico145 structure are highlighted in blue (diazirine photocrosslinkers) and red (alkyne handles).
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A high degree of nonspecific labelling is not uncommon in PAL,
requiring deconvolution of specific and non-specific labelling
events.43,44 PAL on ion channels is particularly challenging:
low expression levels, in combination with low photolabelling
efficiencies common in PAL, often result in only small quan-
tities of labelled protein. Diazirines are the smallest photo-
reactive groups suitable for PAL. Upon irradiation with UV light
(365 nm), they generate highly reactive carbene species that
rapidly insert into proximal C–H or heteroatom–H bonds.37,45
Incorporation of diazirines allows the development of photo-
affinity probes through minimal structural variation of small
molecules.46–48
We hypothesised that PAL would be a suitable approach to
assess cellular target engagement of TRPC1/4/5 modulators.
Here, we report the development of a PAL protocol for TRPC5
channels. Modification of Pico145 with diazirines and alkyne
handles gave a set of photoaffinity probes that functionally
mimic either Pico145 or AM237. Our 2-step labelling protocol
based on PAL and copper-catalysed azide–alkyne cycloadditions
(CuAAC)49 provided the first proof of a direct interaction
between xanthines and TRPC5 in live cells, and allowed the
quantitative assessment of TRPC5 binding by Pico145 in
human cells. This technology may allow assessment of target
engagement of other TRPC1/4/5 modulators and elucidation of
their mode-of-action, and thereby underpin TRPC1/4/5 drug
discovery targeting the xanthine/lipid binding site.
Results
Development of xanthine-based photoaffinity probes
Analysis of semi-quantitative TRPC5 assay data for 621 com-
pounds described in the patent literature22 revealed the N-7 and
C-8 substituents of Pico145 to be the most suitable sites for
incorporation of functional handles (Fig. S1, ESI†). Aiming
for maximal structural similarity to Pico145 itself, we designed
and synthesised a set of four Pico145 photoaffinity probes 4–7
(Fig. 1B), all containing the (trifluoromethyl)(phenyl)diazirine
motif commonly used in diazirine photocrosslinkers.37,50 Pico145-
diazirine (Pico145-DA; 4) and Pico145-diazirine-2 (Pico145-DA2; 6)
are structurally most similar to Pico145 and were made to test
the functional effect of incorporation of a diazirine group.
The compounds designed for our photocrosslinking studies,
Pico145-diazirine-alkyne (Pico145-DAAlk; 5) and Pico145-diazirine-
alkyne-2 (Pico145-DAAlk2; 7) incorporate an additional alkyne
handle that allows bioorthogonal labelling with various reporter
groups, such as biotin or a fluorophore, through CuAAC.
The compounds were synthesised, purified to homogeneity,
and chemically characterised as described in the ESI,† Methods.
Xanthine-based photoaffinity probes are nanomolar TRPC1/4/5
modulators
The effects of xanthine photoaffinity probes on TRPC1/4/5 ion
channel activity were assessed by intracellular calcium ([Ca2+]i)
measurements in HEK T-REx cells expressing tetracycline-
inducible TRPC5-SYFP2, TRPC4-SYFP2, TRPC5-C1 or TRPC4-C1,
using Fura-2 as the calcium indicator (see Methods). To test
TRPC1/4/5 channel inhibition, cells were pre-treated with
increasing concentrations of photoaffinity probes 4–7 before
starting [Ca2+]i monitoring, followed by application of the
TRPC1/4/5 channel activator ()-englerin A (EA). Because initial
experiments with TRPC5-expressing cells revealed concentration-
dependent increases in baseline fluorescence upon pre-incubation
with 4 and 5 (reminiscent of AM23728) these compounds were
further evaluated in activation mode, in which acute effects of
application of 4 and 5 on [Ca2+]i were monitored. The results of
these experiments are depicted in Fig. 2 and ESI,† Fig. S2–S5.
All four photoaffinity probes 4–7modulated TRPC1/4/5 activities in
a concentration-dependent manner, with half-maximal effects at
concentrations in the nanomolar range. Unlike Pico145, and
similar to AM237, Pico145-DAAlk 5 activated TRPC5:C5 channels
(EC50 19 nM; Fig. 2A and B), and inhibited other TRPC1/4/5
channels (IC50 values 46–196 nM; ESI,† Fig. S2). The activation
of TRPC5:C5 by Pico145-DAAlk 5 (100 nM) could be inhibited by
Pico145 in a concentration-dependent manner (IC50 1.8 nM;
Fig. 2C and D). Pico145-DA 4 also activated TRPC5:C5 (EC50
13 nM; ESI,† Fig. S3A and B) and inhibited other TRPC1/4/5
channels (IC50 values 1.4–40 nM; ESI,† Fig. S3C–H), suggesting
that the activating effect on TRPC5:C5 is a consequence of
incorporation of the diazirine group into the C-8 substituent
rather than the alkyne handle on N-7. In contrast, Pico145-
DAAlk2 7 inhibited TRPC5:C5 (IC50 26 nM; Fig. 2E and F) as
well as other TRPC1/4/5 channels (IC50 values 2.0–17 nM; ESI,†
Fig. S4), and similar effects were seen for Pico145-DA2 6
(IC50 values 1.3–18 nM; ESI,† Fig. S5). A comparison of the
EC50 and IC50 values, shown in Table 1, suggests that – in the
context of TRPC1/4/5 channels – Pico145-DA 4 and Pico145-
DAAlk 5 mimic AM237, while Pico145-DA2 6 and Pico145-
DAAlk2 7 mimic Pico145. In addition, the four photoaffinity
probes retained high potency against TRPC1/4/5 channels
compared to AM237 and Pico145. Note that Pico145 potency at
TRPC1/4/5 channels can be reduced by higher EA concentrations,
suggesting competition of the compounds. Therefore, the different
concentrations of EA used as activator in inhibition assays with
TRPC4:C4, TRPC4-C1 and TRPC5-C1 may exaggerate differences in
IC50 values between compounds.
Docking of compounds 4–7 to the Pico145/lipid binding site
of TRPC5:C529 revealed potential binding modes. Similar to
the best predictions for the binding mode of Pico145,29 these
simulations suggest that the xanthine cores of all four com-
pounds 4–7make p-stacking interactions with F576, while their
3-hydroxypropyl groups make hydrogen bonding interactions
with Q573 and W577 (Fig. 3). The top-scoring poses of Pico145-
DA2 6 and Pico145-DAAlk2 7 (Fig. 3C and D) were near-identical
to that of Pico145 in the cryo-EM structure,29 with their
respective OCF3 and O-propargyl groups oriented towards the
hydrophobic tunnel made by L528 and V579. In addition, the
diazirine groups at the para-position of the N-7 benzyl sub-
stituents of 6 and 7 were easily accommodated in the binding
pocket. In contrast, the top-scoring poses for Pico145-DA 4
and Pico145-DAAlk 5 suggest that a slight twist of their C-8
substituents is required to avoid potential clashes between
RSC Chemical Biology Paper
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their (trifluoromethyl)diazirine groups and nearby residues
V610, V579 and L521 (Fig. 3A, B and ESI,† Fig. S6). These
simulations are consistent with the hypothesis that AM237
would also need to rearrange its C-8 aryl substituent to avoid
a clash with L521,29 and suggest that changes to the C-8 aryl
substitution pattern may be a valid strategy for the rational
development of xanthine-based TRPC5:C5 activators. However,
further structural insight into xanthine-based TRPC5:C5 activa-
tion is required, for example through the determination of
open channel structures, which have not been reported to date.
The high similarity of compounds 4–7 to Pico145 and/or
AM237 (in terms of structure, functional effect and potency
as TRPC1/4/5 modulators, and predicted binding modes) in
combination with their increased predicted aqueous solubility
(especially in case of Pico145-DAAlk 5; ESI,† Table S1) are
consistent with properties of well-designed xanthine-based
photoaffinity probes for cellular ligand engagement studies.
Pico145-DAAlk and Pico145-DAAlk 2 allow photoaffinity
labelling of TRPC5 in human cells
To investigate the potential of xanthine-based photoaffinity
probes for TRPC ligand engagement studies, we set out to develop
a photoaffinity labelling (PAL) protocol, making use of the alkyne
handles of the diazirine-alkyne probes Pico145-DAAlk 5 and
Pico145-DAAlk2 7 (Fig. 4). In an initial experiment, 300 nM
Pico145-DAAlk was used to photolabel and – after CuAAC with
TAMRA azide – detect modified proteins by fluorescent gel
scanning (ESI,† Fig. S7A). Labelled proteins were only detected
Fig. 2 Pico145-DAAlk 5 and Pico145-DAAlk2 7 are potent TRPC5:C5 channel modulators. (A) Representative traces from a single 96-well plate (N = 6)
showing an increase in [Ca2+]i in response to 0.1–300 nM Pico145-DAAlk 5 in (Tet+) HEK T-REx cells overexpressing hTRPC5-SYFP2. (B) Concentration–
response data for experiments in (A), showing mean responses  SEM (n/N = 3/18). Responses were calculated at 150–200 s, compared to baseline at
0–55 s. (C) Representative traces from a single 96-well plate (N = 6) showing an inhibition by 0.1–100 nM Pico145 1 of the increase in [Ca2+]i in response
to 100 nM Pico145-DAAlk 5 in (Tet+) HEK T-REx cells overexpressing hTRPC5-SYFP2. (D) Concentration–response data for experiments in (C) showing
mean responses  SEM (n/N = 3/18). Responses were calculated at 150–200 s, compared to baseline at 0–55 s. (E) Representative traces from a single
96-well plate (N = 6) showing an inhibition by 0.3–300 nM Pico145-DAAlk 7 of the increase in [Ca2+]i in response to 10 nM EA in (Tet+) HEK T-REx cells
overexpressing hTRPC5-SYFP2. (F) Concentration–response data for experiments in (E), showing mean responses  SEM (n/N = 3/18). Responses were
calculated at 250–295 s, compared to baseline at 0–55 s.
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in samples that had been subjected to both Pico145-DAAlk 5 and
UV irradiation (ESI,† Fig. S7B and C), and included a protein of
B140 kDa present only in cells that express TRPC5-SYFP2 (ESI,†
Fig. S7C and D). This is consistent with direct binding of Pico145-
DAAlk 5 to TRPC5-SYFP2. However, the aim of this work was to
quantitatively probe interactions between xanthines and TRPC5,
and the faint TRPC5-SYFP2 band was difficult to detect against
the background of other labelled proteins. Therefore, we modified
the photoaffinity labelling protocol to optimise reliable detection
of TRPC5–xanthine interactions (see Methods).
HEK T-REx cells expressing TRPC5-SYFP2 were treated with
Pico145-DAAlk 5 (300 nM), and subjected to irradiation with UV
Table 1 Summarised EC50 and IC50 values for Pico145 1, AM237 3, and photoaffinity probes 4–7 against TRPC1/4/5 channels
a
Compound TRPC5:C5 EC50 (nM) TRPC5:C5 IC50 (nM) TRPC4:C4 IC50 (nM) TRPC4-C1 IC50 (nM) TRPC5-C1 IC50 (nM)
AM237 328 15 7c 3d 4c
Pico145-DA 4 13 40c 1.4c 4.9c
Pico145-DAAlk 5 19 45c 121d 196c
Pico145 123 1.3b 0.35b 0.03b 0.2b
Pico145-DA2 6 18b 16c 1.3c 6.1c
Pico145-DAAlk2 7 26b 17c 2.0c 6.2c
a EA is a negative modulator of Pico145 potency, suggesting that Pico145 is a competitive inhibitor of EA.23 Therefore, lower EA concentrations
used to activate TRPC1/4/5 channels may result in lower IC50 values.
b 10 nM EA was used as activator. c 30 nM EA was used as activator. d 100 nM
EA was used as activator.
Fig. 3 Xanthine-based photoaffinity probes 4–7 have similar predicted binding modes in TRPC5:C5. (A) Top-scoring docked pose of Pico145-DA 4.
(B) Top-scoring docked pose of Pico145-DAAlk 5. (C) Top-scoring docked pose of Pico145-DA2 6. (D) Top-scoring docked pose of Pico145-DAAlk2 7.
All compounds were docked into a 36  36  36 Å3 grid around the Pico145 binding site of TRPC5:C5 (PDB: 6YSN).
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light (365 nm; Analytik Jena AG photocrosslinker) for 25 minutes.
Cells were then washed and lysed, before immunoprecipitation of
TRPC5-SYFP2 using GFP-Trap affinity beads. An on-bead CuAAC
reaction with TAMRA biotin azide (ESI,† Fig. S35) was then
performed, after which proteins were eluted from the GFP-Trap
beads, separated by SDS-PAGE and analysed by western blotting
with Streptavidin-HRP to detect biotin-labelled proteins (Fig. 5A-(i))
and – after membrane stripping – anti-GFP to detect TRPC5-SYFP2
(Fig. 5A-(ii)). Input samples were also probed with anti-GFP
to confirm successful TRPC5-SYFP2 expression (Fig. 5A-(iii)).
Fig. 4 Schematic representation of photoaffinity labelling protocol with Pico145-DAAlk 5 or Pico145-DAAlk2 7. HEK T-REx cells expressing TRPC5-
SYFP2 (A) were incubated with photoaffinity probes and irradiated with UV light (B). Following lysis and GFP-Trap immunoprecipitation (C), photolabelled
TRPC5-SYFP2 was conjugated to TAMRA biotin azide (D) and eluted from GFP-Trap beads (E). Samples were separated using SDS-PAGE and analysed by
western blotting (F and G). TRPC5 representation is based on its cryo-EM structure (PDB: 6AEI).51
Fig. 5 Photoaffinity labelling of TRPC5 with Pico145-DAAlk 5. (A) Representative western blot after experiment depicted in Fig. 3. Samples were blotted
with Streptavidin-HRP (i) and anti-GFP (ii; loading control). Western blot with anti-GFP of input (pre-GFP trap) samples was performed to confirm
successful GFP-SYFP2 expression in HEK T-REx cells (iii). The data show that photolabelling of TRPC5-SYFP2 in HEK T-REx cells (lane 2) is dependent on
expression of TRPC5-SYFP2 (lane 1), treatment with Pico145-DAAlk 5 (300 nM, 30 min, 37 1C; lane 3), UV irradiation (365 nm, Analytik Jena AG
photocrosslinker, 25 min; lane 7), and CuAAC (TAMRA biotin azide 100 mM, CuSO4 1 mM, TCEP 1 mM, TBTA 800 mM; 1 h, 37 1C; lanes 5 and 6). In addition,
Pico145 (10 mM) inhibits photoaffinity labelling with Pico145-DAAlk 5 (lane 4). (B) Densitometry analysis of data presented in (A). po 0.05, all compared to
control (+TRPC5-SYFP2, +Pico145-DAAlk probe; lane 2; one-way ANOVA with Dunnett’s post-test). For ‘–CuAAC’ experiments, CuSO4, TCEP and TBTA
were replaced by their corresponding vehicles (water or DMSO) during the CuAAC step of the protocol. Lane L indicates protein molecular weight ladder.
Pictures of complete western blots are shown in ESI,† Fig. S10.
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This analysis allowed identification (Fig. 5A) and quantification
(Fig. 5B) of TRPC5 photolabelling products. The experiments
revealed a band at ca. 140 kDa, corresponding to the expected
molecular weight of TRPC5-SYFP2 (Fig. 5A, lane 2), which was
absent when TRPC5-SYFP2 expression was not induced with
tetracycline (Fig. 5A, lane 1). Control experiments demonstrated
that Pico145-DAAlk (Fig. 4A, lane 3), UV irradiation (Fig. 5A, lane 7)
and the CuAAC reagents (Fig. 5A, lanes 5 and 6) were all essential
for detection of photolabelled TRPC5. In addition, in a competition
PAL experiment, pre-treatment of cells with Pico145 (10 mM) led to
inhibition of TRPC5 labelling (Fig. 5A, lane 4), suggesting that PAL
is mediated by a specific molecular interaction between TRPC5 and
Pico145-DAAlk 5. Experiments with Pico145-DAAlk2 7 instead of
Pico145-DAAlk 5, which were performed using a custom-built LED-
based photocrosslinker (see ESI,†Methods for details) that allowed
reduction of irradiation time to 1 minute, revealed similar results
(ESI,† Fig. S8 and S9). These results suggest that xanthine-based
photoaffinity probes 5 and 7 can be used for ligand-directed PAL of
TRPC5 protein in human cells, and (through competition assays)
for quantitative assessment of target engagement of TRPC5 modu-
lators (see below).
Dependence of TRPC5 photolabelling on photoaffinity probe
concentration
To investigate the dependence of TRPC5 labelling on photo-
affinity probe concentration, the quantitative PAL experiments
were performed with either 0.3–300 nM Pico145-DAAlk 5 or
0–1000 nM Pico145-DAAlk2 7. Western blots with Streptavidin-
HRP showed concentration-dependent detection of labelled
TRPC5 (Fig. 6A, (i)), while reprobing of membranes with anti-
GFP, and blotting of input samples, showed consistent pull-
down and expression of TRPC5-SYFP2 (Fig. 6A, (ii) and (iii)).
Densitometry analysis showed that TRPC5 labelling increased
with increasing concentrations of Pico145-DAAlk 5 (Fig. 6A and
B) or Pico145-DAAlk2 7 (Fig. 6C and D). Although it would be
tempting to fit dose–response curves to these data, it is possible
that at higher concentration of photoaffinity probes, non-
specific photoaffinity labelling – of other sites than the mod-
ulatory binding site(s) – contributes to signal intensity. Because
clear signals could be detected at 300 nM of either Pico145-
DAAlk 5 or Pico145-DAAlk2 7, this concentration was chosen for
further experiments.
Assessment of Pico145 binding to TRPC5 in human cells by
photoaffinity labelling
The results described above suggest that our quantitative PAL
protocol with Pico145-DAAlk 5 and Pico145-DAAlk2 7, when
performed in competition mode, could potentially provide
an indirect, quantitative method to assess binding of small
molecules to TRPC5 in cells. To test this, HEK T-REx cells
expressing TRPC5-SYFP2 were pre-treated with either DMSO or
0–3000 nM Pico145 1, before performing PAL experiments with
Fig. 6 Dependence of TRPC5 photoaffinity labelling on photoaffinity probe concentration. (A and C) Representative western blots showing
concentration-dependent TRPC5 photolabelling with Pico145-DAAlk 5 (A) and Pico145-DAAlk2 7 (C). HEK T-REx cells overexpressing TRPC5-SYFP2
were treated with 0.3–300 nM Pico145-DAAlk 5 (A) or 0–1000 nM Pico145-DAAlk2 7 (C) for 30 min at 37 1C and irradiated (365 nm). Following lysis and
GFP pull-down, photolabelled TRPC5-SYFP2 was conjugated to TAMRA biotin azide (100 mM) using CuAAC (CuSO4 1 mM, TCEP 1 mM, TBTA 800 mM; 1 h,
37 1C). Samples were separated by SDS-PAGE and blotted with Streptavidin-HRP (i) and anti-GFP (ii; loading control). Western blot with anti-GFP of input
(pre-GFP trap) samples was performed to confirm successful GFP-SYFP2 expression in HEK T-REx cells (iii). (B and D) Densitometry analysis of data
presented in (A) and (C) respectively, showing mean data  SEM (n = 3 independent experiments each). Lane L indicates protein molecular weight ladder.
Pictures of complete western blots are shown in ESI,† Fig. S11.
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Pico145-DAAlk 5 (300 nM) or Pico145-DAAlk2 7 (300 nM).
TRPC5-SYFP2 pull-down and expression was consistent across
samples (Fig. 7A and C), and Pico145 concentration-dependently
inhibited TRPC5 labelling by Pico145-DAAlk 5 (IC50 2.5 nM; Fig. 7A
and B) and Pico145-DAAlk2 7 (IC50 17 nM; Fig. 7C and D).
Interestingly, the IC50 value of Pico145 inhibition of PAL with
Pico145-DAAlk 5 (2.5 nM; Fig. 7A and B) is almost identical to
the IC50 value of Pico145 inhibition of Pico145-DAAlk 5 evoked
calcium entry (1.8 nM; Fig. 2C and D), even when taking into
account the 3-fold difference in the concentration of Pico145-DAAlk
5 used in the respective assays (100 nM in calcium recording;
300 nM in PAL). These data suggest that the functional activity of
xanthine-based TRPC5 modulators such as Pico145 on TRPC5:C5
channels is directly related to a specific binding event between
xanthines and TRPC5 protein.
Discussion
Through minimal structural variation of the most potent
TRPC1/4/5 inhibitor, Pico145, we have developed a set of potent
xanthine-based photoaffinity probes. Pico145-DA 4 and Pico145-
DAAlk 5 functionally mimic AM237; they activate TRPC5:C5
channels but inhibit TRPC4:C4, TRPC5-C1 and TRPC4-C1
channels. In contrast, Pico145-DA2 6 and Pico145-DAAlk2 7
functionally mimic Pico145; they inhibit all TRPC1/4/5 channels
tested. We used Pico145-DAAlk 5 and Pico145-DAAlk2 7 to develop
a new PAL/CuAAC protocol to measure cellular interactions
between xanthines and TRPC5 protein. PAL of TRPC5 was
successful within the same concentration range as the effects
on TRPC5-mediated calcium influx, providing further evidence
that xanthines modulate TRPC5 channels through direct inter-
action with TRPC5 protein, consistent with their behaviour in
excised outside-out patch recordings23,28 and with our cryo-EM
and site-directed mutagenesis studies.29 To the best of our
knowledge, only one previous example of PAL on a TRPC
channel had been reported: Kiyonaka et al. used a pyrazole
derivative (Pyr-PP) incorporating a diazirine photocrosslinker
and a ketone handle (for oxime ligation with a biotin hydro-
xylamine probe) to suggest that the TRPC3 channel inhibitor
Pyr3 directly interacts with TRPC3 protein.39
Competition PAL experiments with Pico145 allowed the
indirect, quantitative assessment of the relative affinities of
Pico145 and photoaffinity probes. The IC50 values determined
for Pico145 in calcium recordings (Fig. 2C and D) and in
competition PAL experiments (Fig. 7A and B) with Pico145-
DAAlk 5 are nearly identical. These results – in combination
with the close structural similarities between Pico145 and
Pico145-DAAlk 5 – are consistent with the hypothesis that
xanthine-based TRPC5:C5 activators (e.g., AM237, Pico145-DA 4,
and Pico145-DAAlk 5) and xanthine-based TRPC5:C5 inhibitors
(e.g., Pico145) bind to identical site(s) of TRPC1/4/5 channels,
Fig. 7 Pico145 concentration-dependently inhibits TRPC5 photoaffinity labelling. (A and C) Representative western blots showing concentration-
dependent inhibition by Pico145 of TRPC5 photolabelling with Pico145-DAAlk 5 (A) or Pico145-DAAlk2 7 (C). HEK T-REx cells overexpressing TRPC5-
SYFP2 were pre-treated with 0–3000 nM Pico145 (30 min, 37 1C) before being treated with 300 nM Pico145-DAAlk 5 (A) or 300 nM Pico145-DAAlk2 7 (C)
for 30 min at 37 1C and irradiated (365 nm). Following lysis and GFP pull-down, TRPC5-SYFP2 was conjugated to TAMRA biotin azide (100 mM) using
CuAAC (CuSO4 1 mM, TCEP 1 mM, TBTA 800 mM; 1 h, 37 1C). Samples were separated by SDS-PAGE and blotted with Streptavidin-HRP (i) and anti-GFP (ii;
loading control). Western blot with anti-GFP of input (pre-GFP trap) samples was performed to confirm successful GFP-SYFP2 expression in HEK T-REx
cells (iii). (B and D) Concentration–response data for experiments (A) and (C) respectively, showing mean data  SEM (n = 3 independent experiments
each). Biotin/GFP was compared to control (0 nM Pico145). Lane L indicates protein molecular weight ladder. Pictures of complete western blots are
shown in ESI,† Fig. S12.
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leading to stabilisation of open or closed TRPC1/4/5 channel
conformations. In addition, our docking studies suggest that,
similar to AM237,29 Pico145-DA 4 and Pico145-DAAlk 5 contain
structural features associated with TRPC5:C5 activation rather
than inhibition (Fig. 3 and ESI,† Fig. S6). Despite extensive
experimentation resulting in successful mass spectrometry-
based peptide mapping of TRPC5 constructs (up to 99%
sequence coverage; not shown), we have not yet been able to
determine which peptides/residues are labelled by xanthine-
based photoaffinity probes. We hypothesise that this is the
result of low efficiency of photolabelling of TRPC5, for which
diazirines are notorious.37,52 Our cryo-EM studies revealed that
up to four molecules of Pico145 can bind to four lipid binding
sites of a TRPC5 tetramer.29 Although it is not yet known how
many binding sites need to be occupied for channel modulation,
xanthine-based TRPC1/4/5 modulators often display Hill slopes
41 in intracellular calcium measurements (Fig. 2 and ESI,†
Fig. S2–S5, and ref. 28), suggesting that a degree of cooperativity
may exist.
Our xanthine-based photoaffinity probes were designed to
have the closest possible structural similarity to their parent
compound, Pico145. The observation that the photoaffinity
probes retain potency against all tested homo- and concate-
meric TRPC1/4/5 channels implies that they can be used to
assess cellular engagement of TRPC1, TRPC4 and TRPC5 in
various tetramers. Considering its potency against TRPC4-C1
and TRPC5-C1 (Table 1), Pico145-DAAlk2 7 may be the most
suitable photoaffinity probe for heteromeric or concatemeric
TRPC1/4/5 channels. In addition, the competition PAL protocol
may allow the assessment of target engagement of other
TRPC1/4/5 modulators as well, and thereby support studies
into their modes-of-action.
Pico145 and HC-070 are the most potent TRPC1/4/5 inhibitors
reported to date, and in vitro screening of these compounds
against hundreds of other proteins (ion channels, receptors,
transporters and enzymes) suggested exquisite selectivity.23,25
Limited aqueous solubility and high plasma protein binding (PPB)
have been highlighted as potential draw-backs of xanthine-based
TRPC1/4/5 modulators, motivating the development of pyridazone-
based TRPC4/5/inhibitors such as GFB-8438.53 Although GFB-8438
has lower potency against TRPC4/5 channels (TRPC4:C4 IC50 =
0.29 mM; TRPC5:C5 IC50 = 0.18–0.28 mM), it has substantially higher
solubility and lower PPB than Pico145,53 consistent with our
calculations (ESI,† Table S1). However, the xanthines Pico145
and HC-070 have been used successfully for the modulation
of TRPC1/4/5 channels in tissues and animals by multiple
academic and industrial groups,21,25–27 suggesting that the lower
solubility and higher PPB of these xanthines may be off-set by
their substantially higher potency. In addition, all four of our
xanthine-based photoaffinity probes (and especially Pico145-DAAlk
5 lacking the non-essential 4-chlorobenzyl substituent on N-7) are
predicted to have higher aqueous solubility than Pico145 (ESI,†
Table S1), suggesting that further modification to the xanthines
could address potential solubility issues if needed. Photoaffinity
labelling with excess Pico145-DAAlk 5 in HEK T-REx cells suggested
modification of multiple proteins (ESI,† Fig. S7), which is
consistent with the hydrophobic nature and of Pico145-DAAlk
5 (favouring non-specific interactions with proteins) and
the indiscriminate nature of diazirine-based photoaffinity
labelling. In future studies, the use of our photoaffinity probes
in comparative mass spectrometry-based chemical proteomics
workflows (for example using Pico145 as a competitor) may
enable the unbiased profiling of true targets and off-targets of
xanthine-based TRPC1/4/5 modulators in cells and tissues.
Our PAL protocol provides the first method for the quanti-
tative assessment of ligand engagement by TRPC5 channels, a
crucial step in the drug discovery process. Because xanthines
bind to a conserved, key modulatory TRPC1/4/5 channel binding
site, competition PAL with xanthine-based photoaffinity probes
may underpin the development of new TRPC1/4/5 modulators as
chemical probes and drug candidates for a wide range of diseases –
including those of the CNS, kidney, heart, and cardiovascular
system.
Methods
Abbreviations and definitions
TRPC, Transient Receptor Potential Canonical; EA, ()-englerin
A; S1P, sphingosine-1-phosphate; HEK T-REx cells; human
embryonic kidney 293 cells stably expressing the tetracycline
repressor protein, allowing tetracycline-inducible recombinant
protein over-expression. TRPC1, TRPC4 and TRPC5 denote the
different proteins or channels incorporating them; TRPC1/4/5
denotes channels composed of TRPC1, TRPC4 and/or TRPC5
(homo- or heteromeric; any ratio); TRPC4:C4 and TRPC5:C5
denote specific homomeric channels; TRPC1:C4 and TRPC1:C5
denote heteromeric channels formed by TRPC1 and either
TRPC4 or TRPC5 (any ratio). TRPC4-C1 and TRPC5-C1 denote
(channels composed of) recombinant, concatemeric proteins
(fusions of TRPC1 at the C-terminus of either TRPC4 or TRPC5
through a short linker);18,23,28,54 [Ca2+]i, intracellular concen-
tration of Ca2+.
Synthesis and characterization
Full synthetic procedures and characterisation data are available in
the ESI,† Methods.
Cell culture and expression systems
HEK T-REx cells expressing inducible TRPC5-SYFP2, TRPC4-
SYFP2, TRPC5-C1 and TRPC4-C1 have been described
previously.18,23,28,54 Cells were maintained in Dulbecco’s
Modified Eagle Medium (DMEM), supplemented with foetal
bovine serum (FBS; 10%), penicillin–streptomycin (100 units
per ml; 100 mg ml1) and blasticidin (10 mg ml1) to maintain
expression of the tetracycline repressor, and zeocin (400 mg ml1)
to maintain incorporation of the relevant TRPC plasmid.
Cells were kept in a humidified incubator at 37 1C at 5% CO2.
Expression of TRPC protein was induced by the addition of
1 mg ml1 tetracycline (Merck, Gillingham, Dorset, UK) to the
culture medium 24 h before experiments.
RSC Chemical Biology Paper
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 1
8 
Se
pt
em
be
r 2
02
0.
 D
ow
nl
oa
de
d 
on
 9
/2
5/
20
20
 3
:4
7:
27
 P
M
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n-
N
on
Co
m
m
er
ci
al
 3
.0
 U
np
or
te
d 
Li
ce
nc
e.
View Article Online
RSC Chem. Biol. This journal is©The Royal Society of Chemistry 2020
Intracellular Ca2+ measurements
[Ca2+]i recordings were carried out using the ratiometric Ca
2+
dye Fura-2. 24 h before experiments, HEK T-REx cells stably
transfected with relevant TRPC plasmids were plated onto
black, clear-bottom, poly-D-lysine coated 96-well plates at
50 000 cells per well. Cells were induced with 1 mg ml1
tetracycline at this point. To load cells with the Fura-2 dye,
media was removed and cells were incubated with standard
bath solution (SBS) containing 2 mM Fura-2 acetoxymethyl ester
(Fura-2 AM; ThermoFisher Scientific, Waltham, MA, USA) and
0.01% pluronic acid (Merck) for 1 h at 37 1C. SBS contained
(in mM): NaCl 135, KCl 5, glucose 8, HEPES 10, CaCl2 1.5 and
MgCl2 1.2. After this incubation, cells were washed with fresh
SBS and incubated at room temperature for a further 30 min.
Immediately prior to the experiment, SBS was removed, and
recording buffer (SBS + 0.01% pluronic acid + 0.01% DMSO)
was added to cells. When assaying cells in inhibition mode,
cells were washed briefly, twice, with SBS after Fura-2 AM
incubation, and then incubated in recording buffer with inhibitors
or DMSO for 30 min at rt. [Ca2+]i was measured in the FlexStation3
(Molecular Devices, Wokingham, UK), by alternating excitation at
340 nm and 380 nm, with an emission at 510 nm. Measurements
were performed at rt for 5 min at 5 s intervals. Compounds used or
tested as TRPC channel activators were dissolved at 2 final
concentration in compound buffer (SBS + 0.01% pluronic acid)
and added to cells after recording for 60 s. When testing
compounds as inhibitors, inhibitors or DMSO were added to
the compound buffer at the same concentration as in the
recording buffer.
Docking studies
The region of the TRPC5:C5 tetrameric structure (PDB: 6YSN)
assigned for docking studies was chosen based upon residues
known to be crucial for Pico145 binding (Y524, L572, Q573,
F576, W577, V579, F599, Y603 and V614). A 36 Å clip of the
TRPC5 structure around these residues was termed as the
receptor for docking studies using Glide (Schro¨dinger Release
2020-1, Glide, Schro¨dinger, LLC, New York, NY, 2020).55 The
TRPC5 pdb file was prepared using the Protein Preparation
Wizard in the Maestro Graphical User Interface (GUI). This
aimed to remove any steric clashes of amino acid side chains
and optimise the position of hydrogen atoms to facilitate
docking studies. The receptor grid was generated using
Schro¨dinger software, allowing docking of ligands in a 36 
36  36 Å3 ‘grid’. Photoaffinity probes 4–7 were imported into
the Maestro GUI and prepared using the LigPrep module to
produce an energy minimised 3D structure. Docking of photo-
affinity probes was carried out using the Glide module of
Schro¨dinger software using the XP mode with flexible ligand
sampling and biased sampling of torsions for all predefined
functional groups. Epik state penalties were added to the
docking score. A maximum of 10 poses were requested in the
output file for each ligand and post-docking minimisation was
carried out. Docking of probes into the defined Pico145 binding
site of TRPC5:C5 produced three poses for each compound with
similar predicted binding energies. These poses were almost
identical with the lowest energy pose making key hydrogen
bonding interactions between the flexible hydroxypropyl groups
and the side chain of Q573. Critical p-stacking interactions were
seen between the xanthine cores and F576, and between the C-8
aryl substituents and Y524. To modify the prepared Pico145
structure to give Pico145-DA (in ESI,† Fig. S6), the build tool in
the Maestro GUI was used to swap the OCF3 for a diazirine-CF3
moiety and this section of the ligand was minimised, leaving
stationary the remaining core of the ligand and amino acids in
proximity to the group. After minimisation, the proximity of the
diazirine moiety to nearby residues was measured.
Calculation of predicted solubility
The predicted log S and log P values for energy-minimised
versions of Pico145, AM237, photoaffinity probes 4–7 and
GFB-8438 (ESI,† Table S1) were calculated using QikProp
(Schro¨dinger Release 2020-1, Glide, Schro¨dinger, LLC, New
York, NY, 2020).
Photoaffinity labelling protocol
Reagents. TAMRA biotin azide (ESI,† Fig. S35) was obtained
from Click Chemistry Tools (Scottsdale, AZ, USA), made up to
10 mM in dry DMSO and stored in aliquots at 20 1C. CuSO4
(Acros) and tris(2-carboxyethyl)phosphine (TCEP; Acros) were
made up in degassed H2O to 50 mM on the day of use and
stored on ice. Tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine
(TBTA; Alfa Aesar) was made up in dry DMSO to 80 mM on the
day of use.
Photoaffinity labelling (PAL) with Pico145-DAAlk 5. HEK
T-REx cells expressing inducible TRPC5-SYFP2 were plated onto
poly-D-lysine coated 10 cm dishes at 7  106 cells per dish,
and left to adhere. After 24 hours, medium was removed and
replaced with fresh medium containing 1 mg ml1 tetracycline
to induce expression of TRPC5-SYFP2. For control cells not
expressing TRPC5-SYFP2, medium was changed to fresh medium
without tetracycline. Cells were used for photoaffinity labelling
24 h after induction. To treat cells for photoaffinity labelling,
medium was removed and cells were washed once in PBS + 1 mM
CaCl2. SBS containing photoaffinity probe (Pico145-DAAlk, 5) was
then added to the cells, and cells were incubated at 37 1C for
30 min. For competition experiments, cells were treated in SBS
containing either DMSO or Pico145 at 37 1C for 30 min before
being replaced with SBS containing photoaffinity probe as well as
DMSO or inhibitor. Cells treated without photoaffinity probe
were treated with DMSO to the same concentration. Following
incubation, lids were removed from the dishes, and cells
irradiated at 365 nm for 25 min using a UV crosslinker (Analytik
Jena AG, Jena, Germany). SBS was then removed, and cells were
washed 3 with PBS + 1 mM Ca2+, followed by addition of
400 ml RIPA buffer containing protease inhibitor cocktail
(EDTA-free; ThermoFisher Scientific). RIPA buffer contained:
Tris/HCl (10 mM, pH 7.5), NaCl (150 mM), EDTA (0.5 mM), SDS
(0.1% w/v), Triton X-100 (1% v/v), deoxycholate (1% w/v). Cells
were scraped into 1.5 ml Eppendorf tubes, and rotated for 1 h at
4 1C. Lysates were then cleared by centrifugation at 10 000g for
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10 min at 4 1C and transferred to fresh tubes. At this stage,
input samples were taken by removal of 20 ml of lysate. To these
input samples, 4 loading buffer (BioRad, Watford, UK) + 10%
beta-mercaptoethanol was added, and samples were boiled at
95 1C for 10 min, then stored at 20 1C. Protein concentrations
for the remaining lysates were quantified using bicinchoninic
acid (ThermoFisher Scientific), followed by immunoprecipita-
tion of TRPC5-SYFP2. TRPC5-SYFP2 was immunoprecipitated
using GFP-Trap agarose (Chromotek, Planegg, Germany)
according to manufacturer’s instructions. Samples were adjusted
to 2.5 mg protein and equal volume in dilution buffer (10 mM
Tris/HCl pH 7.5, 150 mMNaCl, 0.5 mM EDTA), before addition of
20 ml washed bead slurry per sample. Immunoprecipitations were
incubated with end-over-end mixing at 4 1C for 3 h, followed by
3 washes in wash buffer (10 mM Tris/HCl pH 7.5, 150 mM
NaCl, 0.5 mM EDTA), to remove non-specific binders. Following
removal of wash buffer, immunoprecipitated proteins were
resuspended in 74 ml PBS + 1% SDS. Proteins were then tagged
with biotin by on-bead copper-catalysed azide–alkyne cyclo-
addition (CuAAC). Reagents (TAMRA biotin azide 100 mM,
CuSO4 1 mM, TCEP 1mM, TBTA 800 mM) were added to immuno-
precipitated proteins and reactions incubated at 37 1C for 1 h with
shaking at 250 rpm. Reactions were quenched by addition of
10 mM EDTA, and precipitations washed 3 in wash buffer
(3000 g, 5 min). After removal of the last wash, GFP-Trap beads
were resuspended in 45 ml 2% SDS in PBS and 25 ml 4 loading
buffer containing 10% (v/v) betamercaptoethanol, and boiled
for 95 1C for 10 min to dissociate protein from GFP-Trap beads,
and stored at 20 1C prior to SDS-PAGE.
Photoaffinity labelling (PAL) with Pico145-DAAlk2. Experi-
ments using the Pico145-DAAlk2 probe were performed using a
modified method of that described for Pico145-DAAlk. HEK
T-REx cells expressing inducible TRPC5-SYFP2 were plated onto
poly-D-lysine coated 6 well plates at 1  106 cells per well, and
left to adhere for 24 h, before induction of protein expression as
described above. Cells were treated with Pico145-DAAlk2 7 as
described above, but were irradiated at 365 nm for 1 minute
with our home-built LED photocrosslinker (see ESI,† Methods
for details). After lysis in 100 ml RIPA buffer, samples were
quantified and adjusted the lowest concentration (0.5 mg
protein and equal volume) and immunoprecipitated overnight
at 4 1C. CuAAC reactions were then carried out as described for
Pico145-DAAlk.
SDS-PAGE and western blotting. Prior to SDS-PAGE, PAL
samples were centrifuged (5000g, 1 min) to pellet GFP-Trap
beads. PAL and input samples were separated by SDS-PAGE
using 4–15% pre-cast gels (BioRad), before being transferred to
PVDF membrane (Merck Millipore, Burlington, MA, USA) using
wet transfer (350 mA, 1 hour). Following transfer, membranes
were blocked in either 5% BSA (PAL samples) or 5% skimmed
milk (input) in PBS-T for 1 h at rt. Membranes were then
probed with Streptavidin-HRP (PAL samples, 1 : 5000; Thermo-
Fisher Scientific) or anti-GFP (input, 1 : 8000; Abcam, Cambridge,
UK in blocking buffer, overnight at 4 1C). For input samples
membranes were washed in PBS-T (6  5 min, rt) before
incubation in secondary antibody (anti-mouse HRP, 1 : 5000;
ThermoFisher Scientific) for 1 h at rt, and further washing
in PBS-T. For PAL samples, membranes were washed in PBS-T
(6  5 min, rt). Following washing, blots were imaged using
ECL (ThermoFisher Scientific) and G-box (Syngene, Bangalore,
India). To reprobe PAL membranes, membranes were stripped in
Restore Stripping buffer (20 min, rt; ThermoFisher Scientific),
washed in PBS (3  5 min, rt), and blocked in 5% milk in PBS-T.
Membranes were then incubated with anti-GFP (1 : 8000, 2 h, rt),
washed with PBS-T, incubated with anti-mouse HRP (1 : 5000, 1 h,
rt; ThermoFisher Scientific), washed with PBS-T and imaged using
ECL and G-box. Blots were quantified using ImageJ.
Data analysis. Data from [Ca2+]i measurements were analysed
using Microsoft Excel and GraphPad Prism, and presented as
mean  SEM. Statistical tests were performed as described in
figure legends, with significance decided at p o 0.05. [Ca2+]i
assays were performed as 3 independent replicates, with each
replicate containing 6 technical replicates (6 wells of a 96-well
plate; i.e. n/N = 3/18), unless indicated otherwise. Responses were
calculated at the time points indicated, compared to the baseline
at 0–55 s. These results were used to construct concentration–
response curves and calculate EC50 and IC50 values in GraphPad
Prism. Photoaffinity labelling experiments were performed as
3 independent experiments (n = 3), unless described otherwise.
Western blot densitometry analysis was performed using ImageJ,
comparing % biotin/GFP compared to a relevant control sample
as described.
Data availability. The authors declare that the data
supporting the findings of this study are available within the
article and ESI,† or from the corresponding author upon
reasonable request.
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